Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1
Patients co-infected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) are at high risk for liver disease progression. However, interferon-based treatments for HCV infection have significant toxicities, limiting treatment uptake.To assess the all-oral 3 direct-acting antiviral (3D)...
Gardado en:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | inglés |
Publicado: |
2015
|
Acceso en liña: | https://doi.org/10.1001/jama.2015.1328 https://jamanetwork.com/journals/jama/articlepdf/2173265/joi150019.pdf |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|